Kallmann syndrome: Mutations in the genes encoding prokineticin-2 and prokineticin receptor-2
2006

Kallmann Syndrome: Mutations in PROK2 and PROKR2 Genes

Sample size: 192 publication Evidence: moderate

Author Information

Author(s): Dodé Catherine, Teixeira Luis, Levilliers Jacqueline, Fouveaut Corinne, Bouchard Philippe, Kottler Marie-Laure, Lespinasse James, Lienhardt-Roussie Anne, Mathieu Michèle, Moerman Alexandre, Morgan Graeme, Murat Arnaud, Toublanc Jean-Edmont, Wolczynski Slawomir, Delpech Marc, Petit Christine, Young Jacques, Hardelin Jean-Pierre

Primary Institution: Institut Cochin, INSERM U567, Université René Descartes, Paris, France

Hypothesis

The study investigates the genetic mutations associated with Kallmann syndrome, particularly focusing on the PROK2 and PROKR2 genes.

Conclusion

The study identifies mutations in the PROK2 and PROKR2 genes in Kallmann syndrome patients, suggesting a complex genetic basis for the disorder.

Supporting Evidence

  • Mutations in PROK2 and PROKR2 were found in 10% of Kallmann syndrome patients.
  • Loss-of-function mutations in KAL1 and FGFR1 account for only 20% of cases.
  • Some mutations were also detected in clinically unaffected individuals, indicating other factors may be involved.

Takeaway

Kallmann syndrome affects how people smell and their ability to go through puberty, and it can be caused by changes in certain genes.

Methodology

The study sequenced the coding exons of PROKR2 and PROK2 in 192 unrelated individuals affected by Kallmann syndrome.

Limitations

The study does not account for all genetic factors involved in Kallmann syndrome, as mutations in KAL1 and FGFR1 only explain a portion of cases.

Participant Demographics

144 males and 48 females, including 38 familial cases.

Statistical Information

P-Value

p < 0.001

Statistical Significance

p < 0.001

Digital Object Identifier (DOI)

10.1371/journal.pgen.0020175

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication